h1

000567734 001__ 567734
000567734 005__ 20250307110818.0
000567734 0247_ $$2HSB$$aeva23714
000567734 0247_ $$2ISSN$$a0887-6924
000567734 0247_ $$2ISSN$$a1476-5551
000567734 0247_ $$2SCOPUS$$aSCOPUS:2-s2.0-84951569512
000567734 0247_ $$2WOS$$aWOS:000366393900016
000567734 0247_ $$2doi$$a10.1038/leu.2015.245
000567734 0247_ $$2pmid$$apmid:26369986
000567734 037__ $$aRWTH-CONV-092106
000567734 041__ $$aEnglish
000567734 1001_ $$0P:(DE-82)567866$$aWenn, K.$$b0
000567734 245__ $$aTelomere length at diagnosis of chronic phase chronic myeloid leukemia (CML-CP) identifies a subgroup with favourable prognostic parameters and molecular response according to the ELN criteria after 12 months of treatment with nilotinib$$honline, print
000567734 260__ $$aBasingstoke$$bNature Publishing Group$$c2015
000567734 3367_ $$00$$2EndNote$$aJournal Article
000567734 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal
000567734 3367_ $$2BibTeX$$aARTICLE
000567734 3367_ $$2DRIVER$$aarticle
000567734 3367_ $$2DataCite$$aOutput Types/Journal article
000567734 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000567734 591__ $$aGermany
000567734 591__ $$aUSA
000567734 7001_ $$0P:(DE-82)567867$$aTomala, L.$$b1
000567734 7001_ $$0P:(DE-82)080247$$aWilop, S.$$b2
000567734 7001_ $$aVankann, L.$$b3
000567734 7001_ $$0P:(DE-82)097489$$aHasenbank, C.$$b4
000567734 7001_ $$0P:(DE-82)091918$$aFrank, O.$$b5
000567734 7001_ $$aHochhaus, A.$$b6
000567734 7001_ $$aGiles, F. J.$$b7
000567734 7001_ $$aLange, T.$$b8
000567734 7001_ $$aMüller, M. C.$$b9
000567734 7001_ $$0P:(DE-82)IDM06178$$aKoschmieder, Steffen$$b10
000567734 7001_ $$aBeier, F.$$b11
000567734 7001_ $$0P:(DE-82)IDM06069$$aZiegler, Patrick$$b12
000567734 7001_ $$0P:(DE-82)IDM06025$$aBrümmendorf, Tim Henrik$$b13$$eCorresponding author
000567734 773__ $$0PERI:(DE-600)2008023-2$$a10.1038/leu.2015.245$$n12$$p2402-2404$$tLeukemia : normal and malignant hemopoiesis$$v29$$x0887-6924
000567734 909CO $$ooai:publications.rwth-aachen.de:567734$$pVDB
000567734 9141_ $$y2015
000567734 9151_ $$0StatID:(DE-HGF)0031$$2StatID$$aPeer reviewed article$$x0
000567734 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLEUKEMIA : 2014
000567734 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000567734 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000567734 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000567734 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000567734 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000567734 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000567734 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000567734 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000567734 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000567734 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bLEUKEMIA : 2014
000567734 9201_ $$0I:(DE-82)521001-2_20140620$$k521001-2$$lLehrstuhl für Arbeitsmedizin$$x0
000567734 9201_ $$0I:(DE-82)531040-2_20140620$$k531040-2$$lLehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie)$$x1
000567734 961__ $$c2016-02-03$$x2016-02-04$$z2016-02-09
000567734 970__ $$aeva23714
000567734 980__ $$aI:(DE-82)521001-2_20140620
000567734 980__ $$aI:(DE-82)531040-2_20140620
000567734 980__ $$aIMPORT
000567734 980__ $$aUNRESTRICTED
000567734 980__ $$aVDB
000567734 980__ $$ajournal